Newer Diagnostic Methods
The frequent craggy consistency of a breast cancer usually makes it relatively easily palpable, even when it is small in size. However, in large breasts or in deeply seated tumours this may not be so, but I would define 'early cancer' as one in which, even with the most careful palpation, no mass can be felt in the breast.
Iconoclasts have even questioned the value of early diagnosis in influencing the outcome of treatment of breast cancer, but the five-year follow-up figures from the Health Insurance Plan survey in New York (Strax et al. 1970) surely convince one of the value ofearly diagnosis.
Methods of detecting breast tumours are therefore important. I confine my remarks to mammography, xerography and thermography.
Mammography
Any diagnostic method for use in clinical practice should meet at least the following criteria: accuracy, safety, economic feasibility. Is the method accurate ? The percentage of accuracy for mammography in the diagnosis of breast cancer has been claimed to be from 70% to 92%, but I do not propose to go into detail on these figures, for they depend on the age of the group examined. Our own figures in patients over the age of 40 years suggest an accuracy of 82%. Since the commoner and universally accepted X-ray examinations such as barium meal have a similar level of accuracy, and even sophisticated neurological diagnosis dealing with a relatively restricted field seldom has an accuracy (Table 1) . Is it safe? It has been claimed by some epidemiologists that when mammography is used in survey work radiation-induced cancers of the breast may exceed the number of early cases of breast cancer uncovered. It is well to examine critically the evidence on which this alarming statement is based. Mackenzie (1965) found an increased incidence of breast cancer in patients who had had fluoroscopy repeated over many years for control of artificial pneumothorax induced for the treatment of pulmonary tuberculosis. Myrden & Hiltz (1969) , examining virtually the same group of patients found, on comparison with another group of tuberculosis patients who had no such fluoroscopy, that there was a significantly greater frequency of breast cancer. Mettler et al. (1969) showed that patients who received radiation for postpartum mastitis had an increased incidence of breast cancer developing fifteen years later.
The most recent evidence incriminating radiation is reported by the United Nations Scientific Committee on the Effects of Atomic Radiation (1972) , based on the work ofWanebo et al. (1968), who found an increased incidence of breast cancer in patients who had received irradiation from the atomic explosions. The estimated dosage to the breast varied from 60 to 400 rad, depending on distance from the epicentre of the explosion, the average dose being of the order of 100-200 rad ( Table 2) .
The above figures have been variously extrapolated (disregarding some obvious differences such as the biological effects of repeated small doses as opposed to a single large dose) to suggest that a repetitive dose of 8 rad per breast annually, such as might occur in a screening programme, would result in the development among three million women at risk of 200-1440 cases of radiation-induced cancer per annum after a fifteen-year interval.
It would thus appear that malignant change is unlikely to develop until 15 years after the carcinogenic dose has been reached. Bearing in mind the dose levels in mammography it would appear that twenty years would elapse before this radiation dose were reached, so that the possibility of development of a tumour might be anticipated in a further fifteen years, i.e. 35 years after the first examination. Apart from the relatively small numbers in all the reported series the estimated doses are largely conjectural and it is assumed that all breasts are equally susceptible, a highly unlikely premise in such a histologically active structure as breast tissue. Even the radiation experts who have estimated these figures have suggested that 2 rad per breast per year is an acceptable figure, and the carcinogenic risk of doses of this order are probably negligible.
Can satisfactory films be obtained at this dose level? The answer is definitely yes, and is directly related to the technique employed. There is no doubt that when we can identify high risk groups mammography will yield a far higher number of early cancers. One obvious high risk group is the post-mastectomy patient, and the mammogram (Fig 1) may show a cancer developing in the remaining breast. Other high risk groups are those with a family history, discharge from the nipple or localized pain (Samuel 1967) . Low dose mammography technique: Distance between tube and film, type of tube, size of focal spot, all contribute to the dose received by the breast. Dose reduction can, however, be greatly influenced by recording material and suitable choice of screen and film can decrease the dose by a factor of 3-10. By using a single back screen and a blue-light-sensitive film, a dose reduction by a factor of 10 over industrial film can be achieved; a blue-light-sensitive film is the Agfa-Gevaert Medichrome, and the use of this film and a single fine screen combination pioneered by Price & Butler (1971) has reduced the dose by a factor of 10 over unscreened films and is five times less than the conventional film using screens (Table 3) . With minor modifications to the standard automatic processing machine this film can be processed mechanically. Viewing boxes with coloured filters further help interpretation.
Value ofmammography in a screening programme: Table 4 shows the influence of mammography and clinical examination in the detection of unsuspected tumours in a screening programme. It is seen that mammography achieves its main impact in the age group 50-59 years.
Xerography
Xerography is based on a photoelectric rather than a photochemical imaging process. The radiographic positions for breast examination are identical with those used in mammography. Dr John Wolfe, who has pioneered this process has given my colleague Dr G B Young and myself the opportunity of examining some 500 of his xerograms. The major advance is that the deeper structures of the chest wall and the inframammary tissue planes are well shown on the same films as the breast. The dosage rate for xerography is of the order of 3 rad and a higher kilovoltage (35-50 kV) is used than for conventional mammography.
The lateral xerograms are always taken with the patient recumbent and some compression of the breast is essential; special views are taken for the axilla. Considerable experience is needed in the interpretation of these xerograms. It is unlikely that this procedure will be used as a primary screening method in the foreseeable future, at least until the dose rate is reduced. Its use in diagnostic problems is, however, already accepted and some authorities use only this technique. Certainly in the older age groups, where the radiation hazard is not important, there can be no objection to its use.
Thermography
The part that thermography will play in the diagnosis of early breast cancer in the next decade is even more debatable. The overenthusiastic first reports on its use in diagnosis have not been substantiated over the years, but perhaps the method is in danger of being too readily discarded. Our serial records of thermograms of 150 asymptomatic patients over some years have shown that in 2 patients who developed breast cancer thermographic changes were present, some at least one year before a tumour appeared; these changes were not recognized at the time but in the light of subsequent developments they were undoubtedly significant. When we are able to obtain such serial thermographic records, and when the information can be quantified in data form, it may well be that thermography will have a place in detecting breasts in which there is unstable glandular tissue. Such breasts may show unstable vascular patterns which may indicate that they are a high risk group. The use of a rapid and harmless procedure such as thermography may thus come to play an important part in the diagnosis of early breast cancer.
Dr P M Hacking (Newcastle upon Tyne): Mammography is most accurate in postmenopausal women, in those with obese breasts, and in cases where a solitary lesion is present. It is less reliable in younger premenopausal women. Thermography is useful, but the false positive rate is high and the method is therefore of greatest value for detecting any change from previous examinations which may represent the development of new pathology. The problem of the doubtful mammogram persists: clusters of calcified areas may be seen but may be insufficient in number or extent to diagnose intraduct carcinoma conclusively. Ten of these have so far been found in my series of 600 examinations. Biopsy of such a lesion has shown a high degree of correlation with the presence of florid epitheliosis, which may itself be premalignant. Careful follow up is mandatory in this group of patients.
Professor J W Boag (Royal Marsden' Hospital, London): The borders of the lesion and the vascular pattern are much more clearly seen by xeroradiography than by conventional film mammography. A skin dose of 2 or 3 rad per breast is usually needed and to maintain a dose as low as this, good technique is required. Improvement in the sensitivity of the technique of xeroradiography is desirable and research is going on in this direction. Stereoscopic xeroradiography of the breast would then become possible.
Mr C S B Galasko (Oxford): Determination of the extent as well as of the presence of disease is important. Four per cent of patients with operable primary carcinoma show evidence of metastases on clinical examination, chest radiograph or radiographic skeletal survey.
In a series of patients with operable primary tumours and no metastases demonstrated by the above conventional means, 24% had abnormalities demonstrable on skeletal scintigraphy. Skeletal metastases were confirmed in 92% of these patients within three and a halfyears of scintigraphy.
Mr T Hamilton (Edinburgh): The psychological aspects of screening programmes need emphasizing. Most tumours are found on screening in the older age group. In investigation of over 20 000 women in Edinburgh, 11 cancers were discovered in 5 years and all these were in women over 40 years of age. Routine screening of women under the age of 40 is possibly harmful psychologically and probably not justified. Mr Ian Burn (Hammersmith Hospital): To sum up, reliance on mammography in the early diagnosis of cancer of the breast is increasing although every effort must be made to ensure its safety. Mammary thermography appears to be of less value in the differential diagnosis of established symptomatic disease, but it is a safe technique and may well have a future role in identifying asymptomatic disease. Screening programmes carry a number of problems, both physical and psychological, and require careful evaluation before being adopted on a national basis. Pilot studies are already in progress in Edinburgh, Manchester and the Hammersmith/Ealing area under the auspices of the Department of Health, to evaluate the practicality and usefulness of mammary screening.
